Bio-Rad Laboratories BIO Life Science — Depreciation, Depletion and Amortization
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's life science — depreciation, depletion and amortization.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories's life science — depreciation, depletion and amortization?
- Bio-Rad Laboratories (BIO) reported life science — depreciation, depletion and amortization of $18.3M in Q1 2026.
- How has Bio-Rad Laboratories's life science — depreciation, depletion and amortization changed year-over-year?
- Bio-Rad Laboratories's life science — depreciation, depletion and amortization increased by 7.6% year-over-year, from $17M to $18.3M.
- What is the long-term trend for Bio-Rad Laboratories's life science — depreciation, depletion and amortization?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories's life science — depreciation, depletion and amortization has grown at a 8.2% compound annual growth rate (CAGR), from $54.8M to $75M.
- What does life science — depreciation, depletion and amortization mean?
- The non-cash expense allocated to the Life Science segment for the systematic reduction in the value of tangible and intangible assets over their useful lives. This reflects the consumption of capital equipment and acquired technology.